Spots Global Cancer Trial Database for ovarian undifferentiated adenocarcinoma
Every month we try and update this database with for ovarian undifferentiated adenocarcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | NCT02122185 | Brenner Tumor Malignant Ascit... Malignant Pleur... Ovarian Clear C... Ovarian Endomet... Ovarian Mixed E... Ovarian Serous ... Ovarian Undiffe... Recurrent Fallo... Recurrent Ovari... Recurrent Ovari... Recurrent Prima... Stage IIIA Fall... Stage IIIA Ovar... Stage IIIA Ovar... Stage IIIA Prim... Stage IIIB Fall... Stage IIIB Ovar... Stage IIIB Ovar... Stage IIIB Prim... Stage IIIC Fall... Stage IIIC Ovar... Stage IIIC Ovar... Stage IIIC Prim... Stage IV Fallop... Stage IV Ovaria... Stage IV Ovaria... Stage IV Primar... | metformin hydro... placebo Chemotherapy | 18 Years - | University of Chicago | |
| Combination Chemotherapy in Treating Patients With Untreated Ovarian, Peritoneal, or Fallopian Tube Cancer | NCT00003385 | Fallopian Tube ... Ovarian Cancer Primary Periton... | carboplatin paclitaxel pegylated lipos... | - | GOG Foundation | |
| Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors | NCT00066651 | Cervical Cancer Fallopian Tube ... Head and Neck C... Lung Cancer Malignant Mesot... Ovarian Cancer Pancreatic Canc... Primary Periton... | SS1(dsFv)-PE38 ... | 18 Years - | National Cancer Institute (NCI) | |
| Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Persistent Ovarian Epithelial Cancer | NCT00002819 | Ovarian Cancer | carboplatin cyclophosphamid... mitoxantrone hy... paclitaxel autologous bone... peripheral bloo... | - 65 Years | GOG Foundation | |
| Combination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial Cancer | NCT00002568 | Ovarian Cancer | cisplatin paclitaxel conventional su... | - | GOG Foundation | |
| Erlotinib, Docetaxel, and Carboplatin in Treating Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer | NCT00217529 | Fallopian Tube ... Ovarian Cancer Peritoneal Cavi... | pegfilgrastim carboplatin docetaxel erlotinib hydro... | 18 Years - | Fred Hutchinson Cancer Center | |
| Laparoscopic Staging in Patients With Ovarian, Fallopian Tube, or Other Primary Abdominal Cancers | NCT00002538 | Fallopian Tube ... Ovarian Cancer Primary Periton... | laparoscopic su... | 18 Years - | GOG Foundation | |
| Combination Chemotherapy in Treating Patients With Primary Peritoneal or Stage III Epithelial Ovarian Cancer | NCT00003322 | Ovarian Cancer Primary Periton... | cisplatin paclitaxel quality-of-life... | - | GOG Foundation | |
| Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer | NCT00005026 | Ovarian Cancer Primary Periton... | carboplatin paclitaxel topotecan hydro... | - | GOG Foundation | |
| Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian Cancer | NCT00003644 | Ovarian Cancer | carboplatin paclitaxel | - 120 Years | GOG Foundation | |
| Melphalan and Thiotepa Followed by Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer in Complete Remission | NCT00002977 | Ovarian Cancer | filgrastim melphalan thiotepa peripheral bloo... | 18 Years - 60 Years | Fred Hutchinson Cancer Center | |
| Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian Cancer | NCT00003644 | Ovarian Cancer | carboplatin paclitaxel | - 120 Years | GOG Foundation | |
| RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma | NCT00101972 | Cancer | monoclonal anti... | 18 Years - | MacroGenics | |
| S0009 Combination Chemo and Surgery in Stage III or Stage IV Ovarian Cancer | NCT00008138 | Fallopian Tube ... Ovarian Cancer Peritoneal Cavi... | carboplatin paclitaxel debulking surge... | 18 Years - 120 Years | SWOG Cancer Research Network | |
| Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous Chemotherapy | NCT00466960 | Brenner Tumor Fallopian Tube ... Ovarian Clear C... Ovarian Endomet... Ovarian Mixed E... Ovarian Mucinou... Ovarian Serous ... Ovarian Undiffe... Peritoneal Cavi... Recurrent Ovari... Stage III Ovari... Stage IV Ovaria... | sargramostim paclitaxel albu... laboratory biom... immunologic tec... | 18 Years - | University of Washington | |
| Liposomal Doxorubicin and Etoposide in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer | NCT00003380 | Fallopian Tube ... Ovarian Cancer Primary Periton... | etoposide pegylated lipos... | - | GOG Foundation | |
| Recombinant Measles Virus Vaccine Therapy and Oncolytic Virus Therapy in Treating Patients With Progressive, Recurrent, or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer | NCT00408590 | Ovarian Cancer Primary Periton... | carcinoembryoni... oncolytic measl... reverse transcr... laboratory biom... | 18 Years - 120 Years | Mayo Clinic | |
| Immunotoxin Therapy in Treating Patients With Advanced Cancer | NCT00006981 | Cervical Cancer Fallopian Tube ... Head and Neck C... Lung Cancer Malignant Mesot... Ovarian Cancer Pancreatic Canc... Primary Periton... | SS1(dsFv)-PE38 ... | 18 Years - | National Cancer Institute (NCI) | |
| Laparoscopic Staging in Patients With Ovarian, Fallopian Tube, or Other Primary Abdominal Cancers | NCT00002538 | Fallopian Tube ... Ovarian Cancer Primary Periton... | laparoscopic su... | 18 Years - | GOG Foundation | |
| Docetaxel and Capecitabine in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cavity Cancer | NCT00354601 | Fallopian Tube ... Ovarian Cancer Peritoneal Cavi... | capecitabine docetaxel | 18 Years - 120 Years | Wake Forest University Health Sciences | |
| S0009 Combination Chemo and Surgery in Stage III or Stage IV Ovarian Cancer | NCT00008138 | Fallopian Tube ... Ovarian Cancer Peritoneal Cavi... | carboplatin paclitaxel debulking surge... | 18 Years - 120 Years | SWOG Cancer Research Network | |
| Docetaxel and Capecitabine in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cavity Cancer | NCT00354601 | Fallopian Tube ... Ovarian Cancer Peritoneal Cavi... | capecitabine docetaxel | 18 Years - 120 Years | Wake Forest University Health Sciences | |
| Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | NCT00003944 | Fallopian Tube ... Ovarian Cancer Peritoneal Cavi... | filgrastim carboplatin cyclophosphamid... paclitaxel topotecan hydro... peripheral bloo... | 18 Years - | Fox Chase Cancer Center | |
| Carboplatin, Paclitaxel, and Surgery in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer | NCT00331422 | Fallopian Tube ... Ovarian Cancer Peritoneal Cavi... | carboplatin paclitaxel cytoreductive s... | 18 Years - | Masonic Cancer Center, University of Minnesota | |
| Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer | NCT00005026 | Ovarian Cancer Primary Periton... | carboplatin paclitaxel topotecan hydro... | - | GOG Foundation | |
| Paclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian Cancer | NCT00002913 | Brenner Tumor Ovarian Clear C... Ovarian Endomet... Ovarian Mixed E... Ovarian Mucinou... Ovarian Serous ... Ovarian Undiffe... Stage III Ovari... Stage IV Ovaria... | paclitaxel cisplatin topotecan hydro... filgrastim | - | National Cancer Institute (NCI) | |
| Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | NCT00003944 | Fallopian Tube ... Ovarian Cancer Peritoneal Cavi... | filgrastim carboplatin cyclophosphamid... paclitaxel topotecan hydro... peripheral bloo... | 18 Years - | Fox Chase Cancer Center | |
| Immunotoxin Therapy in Treating Patients With Advanced Cancer | NCT00006981 | Cervical Cancer Fallopian Tube ... Head and Neck C... Lung Cancer Malignant Mesot... Ovarian Cancer Pancreatic Canc... Primary Periton... | SS1(dsFv)-PE38 ... | 18 Years - | National Cancer Institute (NCI) | |
| Denileukin Diftitox Used in Treating Patients With Advanced Refractory Ovarian Cancer, Primary Peritoneal Carcinoma, or Epithelial Fallopian Tube Cancer | NCT00357448 | Fallopian Tube ... Ovarian Clear C... Ovarian Endomet... Ovarian Mixed E... Ovarian Mucinou... Ovarian Serous ... Ovarian Undiffe... Peritoneal Cavi... Recurrent Ovari... Stage III Ovari... Stage IV Ovaria... | denileukin dift... intraperitoneal... laboratory biom... enzyme-linked i... flow cytometry | 18 Years - | University of Washington | |
| Liposomal Doxorubicin and Carboplatin in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | NCT00006235 | Fallopian Tube ... Ovarian Cancer Primary Periton... | carboplatin pegylated lipos... | - | GOG Foundation | |
| Combination Chemotherapy in Treating Patients With Primary Peritoneal or Stage III Epithelial Ovarian Cancer | NCT00003322 | Ovarian Cancer Primary Periton... | cisplatin paclitaxel quality-of-life... | - | GOG Foundation | |
| VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer | NCT01666444 | Epithelial Ovar... Fallopian Tube ... Primary Periton... | pegylated lipos... VTX-2337 Placebo | 18 Years - | Celgene | |
| Laparoscopic Staging in Patients With Ovarian, Fallopian Tube, or Other Primary Abdominal Cancers | NCT00002538 | Fallopian Tube ... Ovarian Cancer Primary Periton... | laparoscopic su... | 18 Years - | GOG Foundation | |
| Recombinant Measles Virus Vaccine Therapy and Oncolytic Virus Therapy in Treating Patients With Progressive, Recurrent, or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer | NCT00408590 | Ovarian Cancer Primary Periton... | carcinoembryoni... oncolytic measl... reverse transcr... laboratory biom... | 18 Years - 120 Years | Mayo Clinic | |
| Liposomal Doxorubicin and Carboplatin in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | NCT00006235 | Fallopian Tube ... Ovarian Cancer Primary Periton... | carboplatin pegylated lipos... | - | GOG Foundation | |
| Gene Therapy in Treating Patients With Cancer | NCT00004178 | Cancer | therapeutic aut... | 18 Years - | Roger Williams Medical Center | |
| Combination Chemotherapy, Bone Marrow Transplantation, and Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer | NCT00002600 | Fallopian Tube ... Ovarian Cancer Primary Periton... | filgrastim carboplatin cyclophosphamid... autologous bone... peripheral bloo... | 18 Years - 65 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Combination Chemotherapy Plus IM-862 in Treating Patients With Resected Stage III Ovarian Cancer or Primary Peritoneal Cancer | NCT00017303 | Ovarian Cancer Primary Periton... | carboplatin oglufanide diso... paclitaxel conventional su... | 18 Years - | National Cancer Institute (NCI) | |
| Topotecan Plus Etoposide in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer | NCT00003967 | Fallopian Tube ... Ovarian Cancer Primary Periton... | etoposide topotecan hydro... | 18 Years - | GOG Foundation | |
| Topotecan Plus Etoposide in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer | NCT00003967 | Fallopian Tube ... Ovarian Cancer Primary Periton... | etoposide topotecan hydro... | 18 Years - | GOG Foundation | |
| Carboplatin, Paclitaxel, and Surgery in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer | NCT00331422 | Fallopian Tube ... Ovarian Cancer Peritoneal Cavi... | carboplatin paclitaxel cytoreductive s... | 18 Years - | Masonic Cancer Center, University of Minnesota | |
| Liposomal Doxorubicin and Carboplatin in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | NCT00006235 | Fallopian Tube ... Ovarian Cancer Primary Periton... | carboplatin pegylated lipos... | - | GOG Foundation | |
| Laboratory Study in Predicting Tumor Response to Chemotherapy in Patients With Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer | NCT00897039 | Fallopian Tube ... Ovarian Cancer Primary Periton... | flow cytometry immunohistochem... | - | National Cancer Institute (NCI) | |
| Docetaxel and Capecitabine in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cavity Cancer | NCT00354601 | Fallopian Tube ... Ovarian Cancer Peritoneal Cavi... | capecitabine docetaxel | 18 Years - 120 Years | Wake Forest University Health Sciences | |
| Combination Chemotherapy Plus IM-862 in Treating Patients With Resected Stage III Ovarian Cancer or Primary Peritoneal Cancer | NCT00017303 | Ovarian Cancer Primary Periton... | carboplatin oglufanide diso... paclitaxel conventional su... | 18 Years - | National Cancer Institute (NCI) | |
| Topotecan, High-Dose Cyclophosphamide, Carboplatin, and an Autologous Peripheral Blood Cell Transplant in Treating Patients With Recurrent Ovarian Cancer or Primary Peritoneal Cancer | NCT00652691 | Ovarian Cancer Peritoneal Cavi... | filgrastim carboplatin cyclophosphamid... topotecan hydro... autologous hema... peripheral bloo... | 18 Years - 70 Years | Mayo Clinic | |
| Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Newly Diagnosed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer | NCT00483782 | Fallopian Tube ... Ovarian Cancer Primary Periton... | bevacizumab carboplatin paclitaxel questionnaire a... study of socioe... quality-of-life... | 18 Years - | National Cancer Institute (NCI) | |
| Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian Cancer | NCT00003644 | Ovarian Cancer | carboplatin paclitaxel | - 120 Years | GOG Foundation | |
| TLK286 in Treating Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer | NCT00022347 | Fallopian Tube ... Ovarian Cancer Primary Periton... | canfosfamide hy... | 18 Years - | National Cancer Institute (NCI) | |
| VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer | NCT01666444 | Epithelial Ovar... Fallopian Tube ... Primary Periton... | pegylated lipos... VTX-2337 Placebo | 18 Years - | Celgene | |
| S0009 Combination Chemo and Surgery in Stage III or Stage IV Ovarian Cancer | NCT00008138 | Fallopian Tube ... Ovarian Cancer Peritoneal Cavi... | carboplatin paclitaxel debulking surge... | 18 Years - 120 Years | SWOG Cancer Research Network | |
| Topotecan Plus Etoposide in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer | NCT00003967 | Fallopian Tube ... Ovarian Cancer Primary Periton... | etoposide topotecan hydro... | 18 Years - | GOG Foundation | |
| Erlotinib, Docetaxel, and Carboplatin in Treating Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer | NCT00217529 | Fallopian Tube ... Ovarian Cancer Peritoneal Cavi... | pegfilgrastim carboplatin docetaxel erlotinib hydro... | 18 Years - | Fred Hutchinson Cancer Center | |
| Paclitaxel, Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer | NCT00079430 | Brenner Tumor Fallopian Tube ... Ovarian Clear C... Ovarian Endomet... Ovarian Mixed E... Ovarian Mucinou... Ovarian Serous ... Ovarian Undiffe... Primary Periton... Stage II Ovaria... Stage III Ovari... Stage IV Ovaria... | adjuvant therap... paclitaxel carboplatin bevacizumab | 18 Years - | National Cancer Institute (NCI) | |
| Liposomal Doxorubicin and Etoposide in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer | NCT00003380 | Fallopian Tube ... Ovarian Cancer Primary Periton... | etoposide pegylated lipos... | - | GOG Foundation | |
| Combination Chemotherapy in Treating Patients With Untreated Ovarian, Peritoneal, or Fallopian Tube Cancer | NCT00003385 | Fallopian Tube ... Ovarian Cancer Primary Periton... | carboplatin paclitaxel pegylated lipos... | - | GOG Foundation | |
| RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma | NCT00101972 | Cancer | monoclonal anti... | 18 Years - | MacroGenics |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
